Home LiteratureArticle Details
PMID: 7527084 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.

Journal of virology ·Vol. 69 ·No. 1 ·1995-01-00 ·Pages 222-30

Shotton C, Arnold C, Sattentau Q, Sodroski J, McKeating JA

Abstract

We have identified six monoclonal antibodies (MAbs) mapping to both linear and conformation-dependent epitopes within the V2 region of the human immunodeficiency virus type 1 clone HXB10. Three of the MAbs (12b, 66c, and 66a) were able to neutralize the molecular clones HXB10 and HXB2, with titers in the range of 9.5 to 20.0 micrograms/ml. MAbs mapping to the crown of the V2 loop (12b, 60b, and 74) bound poorly to cell surface-expressed oligomeric gp120, suggesting an explanation for the poor or negligible neutralizing activity of MAbs to this region. In contrast, MAbs 12b and 60b demonstrated good reactivity with recombinant gp120 in an enzyme-linked immunosorbent assay format, suggesting differential epitope exposure between the recombinant and native forms of gp120. Cross-competition analysis of these MAbs and additional V1V2 MAbs for gp120 binding enabled us to assign the MAbs to six groups (A to F). Selection of neutralization escape mutants with MAbs 10/76b and 11/68b, belonging to nonoverlapping competition groups, identified amino acid changes at residues 165 (I to T) and 185 (D to N), respectively. Interestingly, these escape variants remained sensitive to neutralization by the nonselecting V2 MAbs. All MAbs demonstrated good recognition of IIIB viral gp120 yet failed to neutralize nonclonal stocks of IIIB. In addition, MAbs 12b and 62c bound MN and RF viral gp120, respectively, yet failed to neutralize the respective isolates. Cloning and expression of a library of gp120 and V1V2 fragments from IIIB-, MN-, and RF-infected H9 cultures identified a number of polymorphic sites, resulting in antigenic variation and subsequent loss of V2 MAb recognition. In contrast, the V3 region from the clones of the same isolates showed no amino acid changes, suggesting that the V2 region is polymorphic in long-term-passaged laboratory isolates and may account for the reduced antibody recognition observed.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Monoclonal/immunology,isolation & purification Base Sequence Binding Sites, Antibody CHO Cells Cricetinae DNA Primers Epitopes/genetics,immunology HIV Envelope Protein gp120/immunology HIV-1/immunology Molecular Sequence Data Neutralization Tests Polymorphism, Genetic
Chemicals
Antibodies, Monoclonal DNA Primers Epitopes HIV Envelope Protein gp120
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Shotton C
Institute of Cancer Research, Hybridoma Unit, Sutton, Surrey, London.
Arnold C
Sattentau Q
Sodroski J
McKeating J A
References (37)
37 references, click to expand
  1. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
    J Biol Chem. 1990 Jun 25;265(18):10373-82 PMID: 2355006
  2. A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody.
    J Virol. 1994 Jul;68(7):4636-42 PMID: 7515975
  3. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    J Virol. 1991 Feb;65(2):852-60 PMID: 1898972
  4. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.
    J Virol. 1991 Apr;65(4):1710-8 PMID: 2002539
  5. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
    J Immunol. 1991 Jun 15;146(12):4325-32 PMID: 1710248
  6. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
    Science. 1991 Jul 5;253(5015):71-4 PMID: 1905842
  7. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    J Exp Med. 1991 Aug 1;174(2):407-15 PMID: 1713252
  8. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
    J Virol. 1991 Sep;65(9):4777-85 PMID: 1870202
  9. Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    AIDS. 1991 Jul;5(7):829-36 PMID: 1716442
  10. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52 PMID: 1717992
  11. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
    Virology. 1991 Nov;185(1):72-9 PMID: 1718090
  12. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    J Virol. 1992 Jan;66(1):524-33 PMID: 1727497
  13. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.
    J Virol. 1992 Feb;66(2):848-56 PMID: 1370558
  14. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    J Virol. 1992 Apr;66(4):1875-83 PMID: 1548744
  15. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
    J Virol. 1992 Apr;66(4):2577-82 PMID: 1548783
  16. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site.
    AIDS Res Hum Retroviruses. 1992 Apr;8(4):451-9 PMID: 1376134
  17. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51 PMID: 1380261
  18. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1165-70 PMID: 1380263
  19. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
    Virology. 1992 Sep;190(1):134-42 PMID: 1382339
  20. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
    J Virol. 1992 Nov;66(11):6547-54 PMID: 1404602
  21. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9434-8 PMID: 1409653
  22. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.
    Virology. 1992 Dec;191(2):732-42 PMID: 1280382
  23. The role of the V3 loop of gp120 in HIV infection.
    AIDS. 1991;5 Suppl 2:S21-33 PMID: 1845049
  24. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
    J Virol. 1993 Jun;67(6):3232-9 PMID: 7684463
  25. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
    J Virol. 1993 Jun;67(6):3674-9 PMID: 8497077
  26. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    AIDS. 1990 Apr;4(4):307-15 PMID: 2190605
  27. Relation of phenotype evolution of HIV-1 to envelope V2 configuration.
    Science. 1993 Jun 4;260(5113):1513-6 PMID: 8502996
  28. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.
    J Virol. 1993 Jul;67(7):3951-60 PMID: 8510212
  29. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.
    J Virol. 1993 Aug;67(8):4932-44 PMID: 7687306
  30. Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
    J Virol. 1993 Oct;67(10):6136-51 PMID: 7690418
  31. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    J Virol. 1993 Dec;67(12):7383-93 PMID: 7693970
  32. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.
    J Virol. 1994 Jan;68(1):400-10 PMID: 7504740
  33. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
    J Virol. 1994 Jan;68(1):469-84 PMID: 7504741
  34. Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.
    J Virol. 1994 Feb;68(2):974-8 PMID: 7507188
  35. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
    J Virol. 1994 Apr;68(4):2253-9 PMID: 8139010
  36. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    J Virol. 1994 Apr;68(4):2503-12 PMID: 8139032
  37. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.
    J Virol. 1991 Jan;65(1):489-93 PMID: 1702163
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1995-01-00
Pages
222-30
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC188567
Subset
IM
Grants
NIAID NIH HHS · AI28691 · United States
NIAID NIH HHS · AI31783 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com